1
|
Del Sette M, Chiti A and Dinia L:
Intraarterial treatment for acute ischemic stroke. N Engl J Med.
372(1177)2015.PubMed/NCBI View Article : Google Scholar
|
2
|
Wang P, Shao BZ, Deng Z, Chen S, Yue Z and
Miao CY: Autophagy in ischemic stroke. Prog Neurobiol.
163-164:98–117. 2018.PubMed/NCBI View Article : Google Scholar
|
3
|
Writing Group Members. Mozaffarian D,
Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de
Ferranti S, Després JP, et al: Heart disease and stroke
statistics-2016 update: A report From the American Heart
Association. Circulation. 133:e38–e360. 2016.PubMed/NCBI View Article : Google Scholar
|
4
|
Hung IL, Hung YC, Wang LY, Hsu SF, Chen
HJ, Tseng YJ, Kuo CE, Hu WL and Li TC: Chinese herbal products for
ischemic stroke. Am J Chin Med. 43:1365–1379. 2015.PubMed/NCBI View Article : Google Scholar
|
5
|
Li JH, Liu AJ, Li HQ, Wang Y, Shang HC and
Zheng GQ: Buyang huanwu decoction for healthcare: Evidence-based
theoretical interpretations of treating different diseases with the
same method and target of vascularity. Evid Based Complement
Alternat Med. 2014(506783)2014.PubMed/NCBI View Article : Google Scholar
|
6
|
Huang J, Guo W, Cheung F, Tan HY, Wang N
and Feng Y: Integrating network pharmacology and experimental
models to investigate the efficacy of Coptidis and
Scutellaria containing Huanglian Jiedu decoction on
hepatocellular carcinoma. Am J Chin Med. 48:161–182.
2020.PubMed/NCBI View Article : Google Scholar
|
7
|
Zhang J, Liu X, Wu J, Zhou W, Tian J, Guo
S, Jia SS, Meng Z and Ni M: A bioinformatics investigation into the
pharmacological mechanisms of the effect of the Yinchenhao
decoction on hepatitis C based on network pharmacology. BMC
Complement Med Ther. 20(50)2020.PubMed/NCBI View Article : Google Scholar
|
8
|
Lee AY, Park W, Kang TW, Cha MH and Chun
JM: Network pharmacology-based prediction of active compounds and
molecular targets in Yijin-tang acting on hyperlipidaemia and
atherosclerosis. J Ethnopharmacol. 221:151–159. 2018.PubMed/NCBI View Article : Google Scholar
|
9
|
Li XK, Yang HJ, Xiao JC, Zhang J, Zhang J,
Liu M, Zheng Y and Ma L: Network pharmacology based investigation
into the bioactive compounds and molecular mechanisms of
Schisandrae chinensis Fructus against drug-induced liver
injury. Bioorg Chem. 96(103553)2020.PubMed/NCBI View Article : Google Scholar
|
10
|
Xu T, Li S, Sun Y, Pi Z, Liu S, Song F and
Liu Z: Systematically characterize the absorbed effective
substances of Wutou Decoction and their metabolic pathways in rat
plasma using UHPLC-Q-TOF-MS combined with a target network
pharmacological analysis. J Pharm Biomed Anal. 141:95–107.
2017.PubMed/NCBI View Article : Google Scholar
|
11
|
Kim SK and Lee S, Lee MK and Lee S: A
systems pharmacology approach to investigate the mechanism of
Oryeong-san formula for the treatment of hypertension. J
Ethnopharmacol. 244(112129)2019.PubMed/NCBI View Article : Google Scholar
|
12
|
Wang W, Liu T, Yang L, Ma Y, Dou F, Shi L,
Wen A and Ding Y: Study on the multi-targets mechanism of
Triphala on cardio-cerebral vascular diseases based on
network pharmacology. Biomed Pharmacother.
116(108994)2019.PubMed/NCBI View Article : Google Scholar
|
13
|
Zhang J, Liang R, Wang L and Yang B:
Effects and mechanisms of Danshen-Shanzha herb-pair for
atherosclerosis treatment using network pharmacology and
experimental pharmacology. J Ethnopharmacol. 229:104–114.
2019.PubMed/NCBI View Article : Google Scholar
|
14
|
Xu T, Ma C, Fan S, Deng N, Lian Y, Tan L,
Du W, Zhang S, Liu S, Ren B, et al: Systematic understanding of the
mechanism of baicalin against Ischemic stroke through a network
pharmacology approach. Evid Based Complement Alternat Med.
2018(2582843)2018.PubMed/NCBI View Article : Google Scholar
|
15
|
Piñero J, Bravo À, Queralt-Rosinach N,
Gutiérrez-Sacristán A, Deu-Pons J, Centeno E, García-García J, Sanz
F and Furlong LI: DisGeNET: A comprehensive platform integrating
information on human disease-associated genes and variants. Nucleic
Acids Res. 45:D833–D839. 2017.PubMed/NCBI View Article : Google Scholar
|
16
|
Zhang J, Yang B, Wang L and Liang R:
Effects and mechanisms of Danshen-Shanzha herb-pair for
atherosclerosis treatment using network pharmacology and
experimental pharmacology. J Ethnopharmacol. 229:104–114.
2019.PubMed/NCBI View Article : Google Scholar
|
17
|
Rouillard A, Gundersen G, Fernandez N,
Wang Z, Monteiro CD, McDermott MG and Ma'ayan A: The harmonizome: A
collection of processed datasets gathered to serve and mine
knowledge about genes and proteins. Database (Oxford).
2016(baw100)2016.PubMed/NCBI View Article : Google Scholar
|
18
|
Franceschini A, Szklarczyk D, Frankild S,
Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C
and Jensen LJ: STRING v9.1: Protein-protein interaction networks,
with increased coverage and integration. Nucleic Acids Res. 41
(Database issue):D808–D815. 2013.PubMed/NCBI View Article : Google Scholar
|
19
|
Qiao P, Yan H and Wang J: EGb761 protects
brain microvascular Endothelial cells against oxygen-glucose
deprivation-induced injury through lncRNA Rmst/miR-150 axis.
Neurochem Res. 45:2398–2408. 2020.PubMed/NCBI View Article : Google Scholar
|
20
|
Sun Y, Xu DP, Qin Z, Wang PY, Hu BH, Yu
JG, Zhao Y, Cai B, Chen YL, Lu M, et al: Protective cerebrovascular
effects of hydroxysafflor yellow A (HSYA) on ischemic stroke. Eur J
Pharmacol. 818:604–609. 2018.PubMed/NCBI View Article : Google Scholar
|
21
|
Yin F, Zhou H, Fang Y, Li C, He Y, Yu L,
Wan H and Yang J: Astragaloside IV alleviates ischemia
reperfusion-induced apoptosis by inhibiting the activation of key
factors in death receptor pathway and mitochondrial pathway. J
Ethnopharmacol. 248(112319)2020.PubMed/NCBI View Article : Google Scholar
|
22
|
Fritsche KL: Linoleic acid, vegetable oils
& inflammation. Mo Med. 111:41–43. 2014.PubMed/NCBI
|
23
|
Zdunska K, Dana A, Kolodziejczak A and
Rotsztejn H: Antioxidant properties of ferulic acid and its
possible application. Skin Pharmacol Physiol. 31:332–336.
2018.PubMed/NCBI View Article : Google Scholar
|
24
|
Li J, Yu J, Ma H, Yang N, Li L, Zheng DD,
Wu MX, Zhao ZL and Qi HY: Intranasal pretreatment with
Z-Ligustilide, the main volatile component of Rhizoma
Chuanxiong, confers prophylaxis against cerebral ischemia via
Nrf2 and HSP70 signaling pathways. J Agric Food Chem. 65:1533–1542.
2017.PubMed/NCBI View Article : Google Scholar
|
25
|
Wei Y, Liu J, Zhang H, Du X, Luo Q, Sun J,
Liu F, Li M, Xu F, Wei K and Dong J: Ligustrazine attenuates
inflammation and the associated chemokines and receptors in
ovalbumine-induced mouse asthma model. Environ Toxicol Pharmacol.
46:55–61. 2016.PubMed/NCBI View Article : Google Scholar
|
26
|
Pandya RS, Mao L, Zhou H, Zhou S, Zeng J,
Popp AJ and Wang X: Central nervous system agents for ischemic
stroke: Neuroprotection mechanisms. Cent Nerv Syst Agents Med Chem.
11:81–97. 2011.PubMed/NCBI View Article : Google Scholar
|
27
|
Zhang WW, Xu F, Wang D, Ye J and Cai SQ:
Buyang Huanwu Decoction ameliorates ischemic stroke by modulating
multiple targets with multiple components: In vitro evidences. Chin
J Nat Med. 16:194–202. 2018.PubMed/NCBI View Article : Google Scholar
|
28
|
Sowndhararajan K, Deepa P, Kim M, Park SJ
and Kim S: Baicalein as a potent neuroprotective agent: A review.
Biomed Pharmacother. 95:1021–1032. 2017.PubMed/NCBI View Article : Google Scholar
|
29
|
Palozza P: Can beta-carotene regulate cell
growth by a redox mechanism? An answer from cultured cells. Biochim
Biophys Acta. 1740:215–221. 2005.PubMed/NCBI View Article : Google Scholar
|
30
|
Shi X, Fu Y, Zhang S, Ding H and Chen J:
Baicalin attenuates subarachnoid hemorrhagic brain injury by
modulating blood-brain barrier disruption, Inflammation, and
oxidative damage in mice. Oxid Med Cell Longev.
2017(1401790)2017.PubMed/NCBI View Article : Google Scholar
|
31
|
Nabavi SF, Braidy N, Gortzi O,
Sobarzo-Sanchez E, Daglia M, Skalicka-Woźniak K and Nabavi SM:
Luteolin as an anti-inflammatory and neuroprotective agent: A brief
review. Brain Res Bull. 119:1–11. 2015.PubMed/NCBI View Article : Google Scholar
|
32
|
Barreca D, Bellocco E, D'Onofrio G, Nabavi
SF, Daglia M, Rastrelli L and Nabavi SM: Neuroprotective effects of
quercetin: From chemistry to medicine. CNS Neurol Disord Drug
Targets. 15:964–975. 2016.PubMed/NCBI View Article : Google Scholar
|
33
|
Yang G, Wang N, Seto SW, Chang D and Liang
H: Hydroxysafflor yellow a protects brain microvascular endothelial
cells against oxygen glucose deprivation/reoxygenation injury:
Involvement of inhibiting autophagy via class I PI3K/Akt/mTOR
signaling pathway. Brain Res Bull. 140:243–257. 2018.PubMed/NCBI View Article : Google Scholar
|
34
|
Zhao JJ, Song JQ, Pan SY and Wang K:
Treatment with isorhamnetin protects the brain against ischemic
injury in mice. Neurochem Res. 41:1939–1948. 2016.PubMed/NCBI View Article : Google Scholar
|
35
|
Guo C, Ma Y, Ma S, Mu F, Deng J, Duan J,
Xiong L, Yin Y, Wang Y, Xi M and Wen A: The role of TRPC6 in the
neuroprotection of calycosin against cerebral ischemic injury. Sci
Rep. 7(3039)2017.PubMed/NCBI View Article : Google Scholar
|
36
|
Janyou A, Wicha P, Jittiwat J, Suksamrarn
A, Tocharus C and Tocharus J: Dihydrocapsaicin attenuates blood
brain barrier and cerebral damage in focal cerebral
ischemia/reperfusion via oxidative stress and inflammatory. Sci
Rep. 7(10556)2017.PubMed/NCBI View Article : Google Scholar
|
37
|
Robson-Ansley P, Cockburn E, Walshe I,
Stevenson E and Nimmo M: The effect of exercise on plasma soluble
IL-6 receptor concentration: A dichotomous response. Exerc Immunol
Rev. 16:56–76. 2010.PubMed/NCBI
|
38
|
Ma Y, Zechariah A, Qu Y and Hermann DM:
Effects of vascular endothelial growth factor in ischemic stroke. J
Neurosci Res. 90:1873–1882. 2012.PubMed/NCBI View Article : Google Scholar
|
39
|
Ciurea AV, Palade C, Voinescu D and Nica
DA: Subarachnoid hemorrhage and cerebral vasospasm - literature
review. J Med Life. 6:120–125. 2013.PubMed/NCBI
|
40
|
Guo Y: Role of HIF-1a in regulating
autophagic cell survival during cerebral ischemia reperfusion in
rats. Oncotarget. 8:98482–98494. 2017.PubMed/NCBI View Article : Google Scholar
|
41
|
Chen ZZ, Gong X, Guo Q, Zhao H and Wang L:
Bu Yang Huan Wu Decoction prevents reperfusion injury following
ischemic stroke in rats via inhibition of HIF-1 α, VEGF and
promotion β-ENaC expression. J Ethnopharmacol. 228:70–81.
2019.PubMed/NCBI View Article : Google Scholar
|
42
|
Oliveira DMG, Aguiar LT, de Oliveira
Limones MV, Gomes AG, da Silva LC, de Morais Faria CDC and Scalzo
PL: Aerobic training efficacy in inflammation, neurotrophins, and
function in chronic stroke persons: A randomized controlled trial
protocol. J Stroke Cerebrovasc Dis. 28:418–424. 2019.PubMed/NCBI View Article : Google Scholar
|
43
|
Nakajima M, Nito C, Sowa K, Suda S,
Nishiyama Y, Nakamura-Takahashi A, Nitahara-Kasahara Y, Imagawa K,
Hirato T, Ueda M, et al: Mesenchymal stem cells overexpressing
interleukin-10 promote neuroprotection in experimental acute
ischemic stroke. Mol Ther Methods Clin Dev. 6:102–111.
2017.PubMed/NCBI View Article : Google Scholar
|
44
|
Singh N, Sharma G and Mishra V: Hypoxia
inducible factor-1: Its potential role in cerebral ischemia. Cell
Mol Neurobiol. 32:491–507. 2012.PubMed/NCBI View Article : Google Scholar
|
45
|
Franke TF: PI3K/Akt: Getting it right
matters. Oncogene. 27:6473–6488. 2008.PubMed/NCBI View Article : Google Scholar
|
46
|
Gao X, Zhang H, Takahashi T, Hsieh J, Liao
J, Steinberg GK and Zhao H: The Akt signaling pathway contributes
to postconditioning's protection against stroke; the protection is
associated with the MAPK and PKC pathways. J Neurochem.
105:943–955. 2008.PubMed/NCBI View Article : Google Scholar
|
47
|
Eltzschig HK and Eckle T: Ischemia and
reperfusion-from mechanism to translation. Nat Med. 17:1391–1401.
2011.PubMed/NCBI View Article : Google Scholar
|